Atalanta
41 employees on LinkedIn · 9 known investors
Find your way into Atalanta
Sign up to see every warm intro you have to Atalanta
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Atalanta team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Atalanta is developing treatment options for intractable central nervous system diseases using RNA interference technology. The company was founded by leading experts in RNAi research.
Investors · 9
How we know: F-Prime Capital's portfolio page · a partner's Signal profile · insideprecisionmedicine.com · Not right? Tell us
How we know: Novartis Venture Fund's portfolio page · funding news · insideprecisionmedicine.com · Not right? Tell us
How we know: RiverVest Venture Partners's portfolio page · a partner's Signal profile · funding news · insideprecisionmedicine.com · Not right? Tell us
How we know: Sanofi Ventures's portfolio page · a partner's Signal profile · funding news · insideprecisionmedicine.com · the VCSheet dataset · Not right? Tell us
How we know: funding news · insideprecisionmedicine.com · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BFeb 2025
EQT Life Sciences (lead), Sanofi Ventures (lead), abrdn, F-Prime Capital, GHR Foundation, Mirae Asset Financial Group, Novartis Venture Fund, Pictet Alternative Advisors, RiverVest Venture Partners
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Atalanta do?
- Atalanta is developing treatment options for intractable central nervous system diseases using RNA interference technology. The company was founded by leading experts in RNAi research.
- Who are Atalanta's investors?
- Atalanta's investors include F-Prime Capital, Novartis Venture Fund, RiverVest Venture Partners, Sanofi Ventures, abrdn plc, EQT Life Sciences.




